Iron is essential to the production of myocardial energy and proteins critical for cardiovascular function. Nearly 50% of patients with heart failure with reduced ejection fraction (HFrEF) meet current criteria for iron deficiency, and there has been considerable interest in intravenous repletion of iron stores as a therapeutic strategy to improve HFrEF outcomes. However, the data on intravenous iron therapy in HFrEF have been mixed.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout

References
Kalra, P. R. et al. Lancet https://doi.org/10.1016/S0140-6736(22)02083-9 (2022).
von Haehling, S., Ebner, N., Evertz, R., Ponikowski, P. & Anker, S. D. JACC Heart Fail. 7, 36–46 (2019).
Ponikowski, P. et al. Lancet 396, 1895–1904 (2020).
McDonagh, T. A. et al. Eur. Heart J. 42, 3599–3726 (2021).
Heidenreich, P. A. et al. Circulation 145, e895–e1032 (2022).
Sawicki, K. T. & Ardehali, H. Ann. Intern. Med. 175, HO2–HO3 (2022).
Ghafourian, K., Shapiro, J. S., Goodman, L. & Ardehali, H. JACC Basic Transl. Sci. 5, 300–313 (2020).
Masini, G. et al. J. Am. Coll. Cardiol. 79, 341–351 (2022).
Petrak, J. et al. Biochim. Biophys. Acta Gen. Subj. 1863, 703–713 (2019).
Melenovsky, V. et al. Eur. J. Heart Fail. 19, 522–530 (2017).
Docherty, K. F. et al. Circulation 146, 980–994 (2022).
Fang, X., Ardehali, H., Min, J. & Wang, F. Nat. Rev. Cardiol. https://doi.org/10.1038/s41569-022-00735-4 (2022).
Zoller, H. et al. Gut https://doi.org/10.1136/gutjnl-2022-327897 (2022).
Sawicki, K. T. & Ardehali, H. Eur. Heart J. 43, 345–346 (2022).
Sawicki, K. T. & Ardehali, H. Circulation 144, 253–255 (2021).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sawicki, K.T., Ardehali, H. Ferric derisomaltose therapy and heart failure: implications and molecular insights. Nat Cardiovasc Res 2, 3–5 (2023). https://doi.org/10.1038/s44161-022-00202-w
Published:
Issue date:
DOI: https://doi.org/10.1038/s44161-022-00202-w